3//SEC Filing
HighCape Partners QP II, L.P. 3
Accession 0001104659-22-127364
CIK 0001708527other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 4:30 PM ET
Size
11.3 KB
Accession
0001104659-22-127364
Insider Transaction Report
Form 3
HighCape Partners II, L.P.
10% Owner
Holdings
- 735,000(indirect: See footnotes)
Class A Common Stock
HighCape Partners GP II, LLC
10% Owner
Holdings
- 735,000(indirect: See footnotes)
Class A Common Stock
HighCape Partners GP II, L.P.
10% Owner
Holdings
- 735,000(indirect: See footnotes)
Class A Common Stock
HighCape Partners QP II, L.P.
10% Owner
Holdings
- 735,000(indirect: See footnotes)
Class A Common Stock
Footnotes (3)
- [F1]Includes 15,023 shares of Class A Common Stock held of record by HighCape Partners II, L.P. and 719,977 shares of Class A Common Stock held of record by HighCape Partners QP II, L.P.
- [F2]Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP II, LLC, which is the general partner of HighCape Partners GP II, L.P., which is the general partner of each of HighCape Partners II, L.P. and HighCape Partners QP II, L.P.
- [F3]The securities reported herein do not include: (i) 53,818 shares of Class A Common Stock held of record by HighCape Partners, L.P.; (ii) 4,001,428 shares of Class A Common Stock held of record by HighCape Partners QP, L.P.; (iii) 499,145 shares of Class A Common Stock held of record by HighCape Co-Investment Vehicle I, LLC; (iv) 259,282 shares of Class A Common Stock held of record by HighCape Co-Investment Vehicle II, LLC; and (v) 48,931 shares of Class A Common Stock held of record by HighCape Capital, L.P., which securities were included on a Form 4 filed by those entities on December 7, 2022.
Documents
Issuer
AZIYO BIOLOGICS, INC.
CIK 0001708527
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001770972
Filing Metadata
- Form type
- 3
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 4:30 PM ET
- Size
- 11.3 KB